© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, ORIC Pharmaceuticals, Inc. (ORIC) shows an Average True Range (ATR) of 0.87 and an Enterprise Value of 531.23M. Its average trading volume over the past 3 months is 1.53M, indicating liquidity. These fundamental metrics provide insight into ORIC's underlying financial health and market activity.
| ATR | 0.87 |
| Enterprise Value | 531.23M |
| Avg Vol (3 Months) | 1.53M |
| Avg Vol (10 Days) | 1.16M |
ORIC Pharmaceuticals, Inc. (ORIC) technical indicators as of September 11, 2026: the SMA 20 is 22.03%, SMA 50 at 32.36%, and SMA 200 at 29.02%. The RSI 14 value is 70.8, suggesting its current momentum. These technical analysis signals help assess ORIC's price trends and potential future movements.
| SMA 20 | 22.03% |
| SMA 50 | 32.36% |
| SMA 200 | 29.02% |
| RSI 14 | 70.8 |
ORIC Pharmaceuticals, Inc. (ORIC) stock performance overview as of September 11, 2026: The 52-week high is N/A (currently -9.58% below), and the 52-week low is N/A (currently 246.59% above). Over the past year, ORIC's performance is N/A, compared to the S&P 500's N/A change.
| 52-Week High | N/A |
| 52-Week High Chg | -9.58% |
| 52-Week Low | N/A |
| 52-Week Low Chg | +246.59% |
| S&P 500 52-Week Chg | N/A |